Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ciba Settles Cooper Lens Dispute; New CEO Brings Global Marketing Fluency

This article was originally published in The Gray Sheet

Executive Summary

CooperVision will continue to sell its cosmetic contact lenses worldwide under an agreement with Ciba Vision that allows the firm to license Ciba colored contact lens patents in return for product royalties

You may also be interested in...



Ciba Vision Protects Colored Lens Market Share In Latest Patent Suit v. OSI

Ciba Vision/Wesley Jessen's most recent patent infringement lawsuit, filed Nov. 6 against Ocular Sciences, demonstrates the large market potential of colored contact lenses

Ciba Vision Protects Colored Lens Market Share In Latest Patent Suit v. OSI

Ciba Vision/Wesley Jessen's most recent patent infringement lawsuit, filed Nov. 6 against Ocular Sciences, demonstrates the large market potential of colored contact lenses

FDA Pre-Approval Of Commercial Speech: “Coming Soon” To DTC Device Ads?

AdvaMed is urging FDA to consider a pre-approval policy for direct-to-consumer advertising within the Center for Devices & Radiological Health

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017245

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel